Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
Twitter summary: FDA grants âtentative approvalâ to Lilly/BIâs Basaglar â new insulin option will be an alternative to Lantus in future. On August 18, Eli Lilly and Boehringer Ingelheim (BI) announced that the FDA granted âtentative approvalâ to Basaglar (insulin glargine injection) for type 1 and type 2 patients.